Plasminogen-binding human alpha 2-plasmin inhibitor is converted by human granulocyte elastase into its non-plasminogen-binding and finally into the inactive form of the inhibitor. This degradation of the plasmin inhibitor, described earlier as "spontaneously" occurring conversion, is shown in dodecyl sulfate polyacrylamide gel electrophoresis, in two-dimensional immunoelectrophoresis and by measuring the kinetics of plasmin inhibition. Experiments in the presence of normal human plasma required unphysiologically high concentrations of elastase to inactivate alpha 2-plasmin inhibitor, suggesting a role of elastase in this type of indirect fibrinolysis in a microenvironment only and not in systemic events.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1515/bchm2.1984.365.1.19 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Risk Factors for Mortality in Critically Ill Patients with Coagulation Abnormalities: A Retrospective Cohort Study.
Curr Med Sci
October 2024
Department of Hematology, Qilu Hospital of Shandong University, Jinan, 250012, China.
Article Synopsis
- The study investigates the link between coagulation abnormalities and mortality risk in ICU patients, finding that certain coagulation markers are significant indicators of patient outcomes.
- Researchers analyzed data from 451 ICU patients over a 28-day period, identifying that factors like elevated thrombin-antithrombin complex and prolonged prothrombin time are independent mortality risk factors.
- The findings suggest that monitoring coagulation markers could lead to targeted therapies that improve survival rates in ICU patients with coagulation issues.
Detection of factor XIII inhibitors in 33 patients with autoimmune factor XIII deficiency in Japan.
Int J Hematol
October 2024
Department of Molecular Patho-Biochemistry and Patho-Biology, Yamagata University School of Medicine, Yamagata, 990-9585, Japan.
Article Synopsis
- Autoimmune factor XIII (FXIII) deficiency (AiF13D) is a rare disease caused by anti-FXIII autoantibodies that disrupt FXIII function, classified into three types with different effects on FXIII activity.
- A new assay, called the PI-BAPA assay, has been developed to effectively detect types Aa and Ab FXIII inhibitors which can be lethal if missed by standard tests.
- This assay demonstrated high specificity and sensitivity in trials with 128 plasma samples, outperforming traditional methods, and is now being utilized for diagnosing AiF13D.
[Autoimmune acquired coagulation factor XIII/13 deficiency caused by type Ab anti-FXIII-A autoantibody].
Rinsho Ketsueki
January 2024
Department of Molecular Pathobiochemistry and Pathobiology, Yamagata University School of Medicine.
An 88-year-old man became unconscious and was admitted to our hospital due to severe anemia. Extensive subcutaneous hemorrhage around the chest and back and pectoralis major muscle hematoma were observed. Coagulation screening tests showed moderately reduced factor XIII/13 (FXIII) activity.
View Article and Find Full Text PDFCharacterization and Usefulness of Clot-Fibrinolysis Waveform Analysis in Critical Care Patients with Enhanced or Suppressed Fibrinolysis.
Thromb Haemost
January 2024
Sysmex Corporation, Kobe, Japan.
Introduction: Recently, clot-fibrinolysis waveform analysis (CFWA), which is a coagulation and fibrinolysis global assay based on assessing the activated partial thromboplastin time with tissue-type plasminogen activator, was developed. This study aimed to investigate the characteristics of CFWA using plasma samples from patients in the critical care unit.
Materials And Methods: The fibrinolysis times using CFWA were measured in 298 plasma samples.
Circulating Syndecan-1 Levels Are Associated with Chronological Coagulofibrinolytic Responses and the Development of Disseminated Intravascular Coagulation (DIC) after Trauma: A Retrospective Observational Study.
J Clin Med
June 2023
Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Ehime University, Toon 791-0295, Ehime, Japan.
Background: The purpose of this study was to evaluate the association between endotheliopathy represented by high levels of circulating syndecan-1 (SDC-1) and coagulofibrinolytic responses due to trauma, which can lead to disseminated intravascular coagulation (DIC).
Methods: We retrospectively evaluated 48 eligible trauma patients immediately admitted to our hospital and assessed SDC-1 and coagulofibrinolytic parameters for 7 days after admission. We compared the longitudinal changes of coagulofibrinolytic parameters and SDC-1 levels between two groups (high and low SDC-1) according to median SDC-1 value on admission.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!